Wash Out the Lesion, Don't Jam the Signal | The Pained Brain, Chapter 14

Tendinopathy metabolic screening

Tendinopathy as a Metabolic Signal: Screening Before the Procedure

Recalcitrant tendinopathy is a metabolic signal: an A1c above 5.7 percent, the triglyceride-to-HDL pattern and the metabolic syndrome all track with it, even when body mass index is matched. Screening those numbers and body composition before the procedure sets expectations and puts metabolic work on the same care plan as the tendon.

Chronic tendinopathy arrives as a musculoskeletal complaint and leaves as a referral. The glycemic, lipid and body composition data that predict how it responds are rarely part of the handoff.

Recalcitrant tendinopathy usually enters the chart as a musculoskeletal complaint and leaves it as a referral: to physical therapy, to an injection, to a percutaneous tenotomy, occasionally to a stimulator trial. What rarely travels with it is the metabolic context that predicts how the tendon will respond to any of those. The chapter video, Wash Out the Lesion, Don’t Jam the Signal, presents chapter 14 of The Pained Brain by Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Dr. KrisJay Fucanan, MD. The procedure evidence and its grading are in the book companion for chapter 14; the focus here is what a primary care, pain, endocrine or geriatric practice should measure around that decision.

Is tendinopathy linked to the metabolic syndrome?

A Danish population cohort followed 5,856 people for three years. A hemoglobin A1c above 5.7 percent was associated with approximately a threefold risk of hospital-treated tendon injury in the lower extremities, and the metabolic syndrome with approximately 2.5 times the risk in upper and lower extremities alike. In a case-control study of 60 patients with midportion Achilles tendon disease against 60 controls matched for age, sex and body mass index, patients had higher triglycerides, lower HDL, a higher triglyceride-to-HDL ratio and higher apolipoprotein B. A pooled analysis of 17 studies and 2,612 participants found triglycerides 0.33 mmol/L and LDL cholesterol 1.00 mmol/L higher in people with tendon pain or altered tendon structure.

Adiposity adds its own gradient. Across 22 studies and 49,914 participants, obesity carried odds ratios of 3.81 for Achilles tendon disease in class I and 6.56 in class III, and 2.97 for plantar fascia disease; a body mass index above 27 carried an odds ratio of 3.7 for plantar fasciopathy, most strongly outside athletic populations. The evidence tier is observational and largely case-control, with reverse causation possible. The direction is nonetheless consistent, and the BMI-matched lipid finding argues that the signal is metabolic rather than purely mechanical.

How does a metabolic finding change tendinopathy management?

Loading is the treatment the rest of the plan exists to enable. In a randomized trial of 204 people with gluteal tendon pain, education plus exercise outperformed corticosteroid injection by 20.4 percent in global success at one year, a number needed to treat of 4.9. Pooled dose data favor added external load over body weight, 1.4 against 0.9 in within-arm effect size, and less-than-daily over daily sessions.

The terrain changes how far that loading goes. In a retrospective comparison of 28 patients with the metabolic syndrome and 28 matched controls on an identical eccentric program for insertional Achilles tendon disease, the metabolic group reported higher pain throughout follow-up, lower satisfaction and greater analgesic use. After bariatric surgery in 163 patients with plantar fasciitis, a mean excess weight loss of 51.0 percent accompanied symptom resolution in 90 percent, without a way to separate unloading from metabolic change.

Practically, a documented metabolic phenotype does three things. It sets expectations before a procedure or a rehabilitation block, so that a slow response is interpreted rather than escalated. It puts metabolic work on the same care plan as the tendon work instead of in a separate silo. And it gives the interventionalist and therapist the context their notes usually lack; only 44 percent of published tenotomy studies prescribed structured rehabilitation at all. The social driver is the handoff itself: each specialist in the chain sees the tendon, and nobody is assigned the terrain.

Which tendinopathy patients should be screened?

Tendon pain or plantar fasciopathy that has not settled with an adequate loading program.
Lower-extremity tendon disease in a patient with obesity, or with a body mass index above 27 and heel pain.
Any patient being referred for a percutaneous tendon procedure or a neuromodulation evaluation for tendon-region pain.
Patients previously told they are not diabetic whose last A1c sat in the prediabetic band.
A medication history that includes fluoroquinolone exposure, which carried an odds ratio of 3.95 for Achilles tendinitis in pooled studies, documented as a risk factor in the history.

Practice-level criteria are summarized under selection criteria.

What Measura measures in this pathway

Measura [Cardiometabolic and Autonomic Health Analysis] is a testing service; it does not perform tenotomy, injections or any treatment, and it reports to the ordering physician. The relevant measurements are laboratory panels for the glycemic and lipid picture, and bioimpedance body composition to separate lean from fat mass in patients whose BMI understates or overstates their metabolic risk. Where an older patient with hip or foot tendon pain also reports unsteadiness or a prior fall, vestibular and balance testing belongs in the same visit, and the cognitive assessment and fall prevention workflow keeps that documentation together.

Standing orders and documentation

The reproducible version is a standing order that attaches metabolic labs and body composition to any referral for recalcitrant tendinopathy, so the baseline exists before the procedure note does. At an annual wellness visit, the same results support the cardiometabolic documentation that HEDIS and value-based care frameworks already track, as quality documentation rather than as an indication in itself. Repeat measurement during rehabilitation shows whether the terrain is moving alongside the tendon. The related question of what precision a procedure needs is in the diagnostic nerve block referral.

The limits, stated once

Percutaneous tenotomy is graded Level 4 by systematic review, with no sham-controlled trial of tissue removal yet, and nerve stimulation has never been tested against a tendon lesion in a randomized trial. The metabolic associations are observational. The practice position is unchanged by either fact: a procedure is a bridge that buys a window for loading, and the metabolic terrain decides whether that window becomes a repair. Measure the terrain first, and keep measuring it. Patients can read the patient version. The joint version of this pattern shows up in hands that bear no weight, laid out in metabolic screening in osteoarthritis.

Frequently asked questions

Is tendinopathy associated with insulin resistance?

The association is consistent across designs. Patients with Achilles tendon disease showed the triglyceride-to-HDL pattern of insulin resistance against BMI-matched controls, and a prospective Danish cohort linked an A1c above 5.7 percent to about a threefold risk of lower-extremity tendon injury. The data are observational, so causation is not established. The wider clinical rationale for cardiometabolic measurement in musculoskeletal patients follows the same reasoning.

Which laboratory values are most useful in recalcitrant tendinopathy?

The studied markers are hemoglobin A1c, triglycerides, HDL and LDL cholesterol, and apolipoprotein B, with the triglyceride-to-HDL ratio as a practical summary. The book’s own rehabilitation planning begins with fasting insulin. Uric acid has been linked to Achilles rupture rather than chronic tendon disease. Available panels and ordering are described under laboratory panels.

Does metabolic status change rehabilitation expectations?

It appears to. Patients with the metabolic syndrome on an identical eccentric program for insertional Achilles tendon disease had more pain, less satisfaction and more analgesic use than matched controls over follow-up. Documenting that phenotype lets the team read a slow response as expected rather than as treatment failure, and address the terrain in parallel. Outcome tracking is covered under what changes for the patient.

How can metabolic testing be built into tendon referrals?

A standing order tied to the referral itself is the most reproducible approach: metabolic labs and body composition drawn when a patient is sent for injection, tenotomy or neuromodulation evaluation. That keeps the decision from depending on the individual clinician and puts the baseline in place before intervention. Templates and scope are outlined in standing orders for screening.

Where do Measura results go, and who acts on them?

Results return to the ordering physician, who interprets them in context and decides on management; Measura does not diagnose disease on its own or treat. Findings can be filed as structured data so they remain visible when later procedure and therapy notes arrive. The mechanics are described in getting results into the record.

How do you heal tendinopathy?

Loading is the treatment the rest of the plan exists to enable. In a randomized trial of 204 people with gluteal tendon pain, education plus exercise beat corticosteroid injection by 20.4 percent in global success at one year, a number needed to treat of 4.9. Pooled dose data favor added external load over body weight and less-than-daily over daily sessions. The metabolic terrain decides how far that loading goes.

Add the terrain to the tendon referral

Learn how the Measura protocol attaches metabolic labs and body composition to musculoskeletal referrals, with results returned to the ordering physician.

Send a message

4477 Woodson Rd, Suite 201, St. Louis, MO 63134. Monday to Friday, 9:00 a.m. to 5:00 p.m. Please do not send symptoms, diagnoses or images through a web form — a website form is not a secure medical channel. Send your name and number and we will call you back.

References

Skovgaard, D., Siersma, V. D., Klausen, S. B., Visnes, H., Haukenes, I., Bang, C. W., Bager, P., Grävare Silbernagel, K., Gaida, J., Magnusson, S. P., Kjaer, M., & Couppé, C. (2021). Chronic hyperglycemia, hypercholesterolemia, and metabolic syndrome are associated with risk of tendon injury. Scandinavian Journal of Medicine & Science in Sports, 31(9), 1822–1831. https://doi.org/10.1111/sms.13984
Gaida, J. E., Alfredson, L., Kiss, Z. S., Wilson, A. M., Alfredson, H., & Cook, J. L. (2009). Dyslipidemia in Achilles tendinopathy is characteristic of insulin resistance. Medicine and Science in Sports and Exercise, 41(6), 1194–1197. https://doi.org/10.1249/MSS.0b013e31819794c3
Tilley, B. J., Cook, J. L., Docking, S. I., & Gaida, J. E. (2015). Is higher serum cholesterol associated with altered tendon structure or tendon pain? A systematic review. British Journal of Sports Medicine, 49(23), 1504–1509. https://doi.org/10.1136/bjsports-2015-095100
Macchi, M., Spezia, M., Elli, S., Schiaffini, G., & Chisari, E. (2020). Obesity Increases the Risk of Tendinopathy, Tendon Tear and Rupture, and Postoperative Complications: A Systematic Review of Clinical Studies. Clinical Orthopaedics and Related Research, 478(8), 1839–1847. https://doi.org/10.1097/CORR.0000000000001261
van Leeuwen, K. D., Rogers, J., Winzenberg, T., & van Middelkoop, M. (2015). Higher body mass index is associated with plantar fasciopathy/’plantar fasciitis’: systematic review and meta-analysis of various clinical and imaging risk factors. British Journal of Sports Medicine, 50(16), 972–981. https://doi.org/10.1136/bjsports-2015-094695
Park, Y. H., Kim, W., Kim, J. Y., Choi, G. W., & Kim, H. J. (2021). Clinical Impact of Metabolic Syndrome on Eccentric Exercises for Chronic Insertional Achilles Tendinopathy. Journal of Foot and Ankle Surgery, 61(4), 726–729. https://doi.org/10.1053/j.jfas.2021.03.020
Mellor, R., Bennell, K., Grimaldi, A., Nicolson, P., Kasza, J., Hodges, P., Wajswelner, H., & Vicenzino, B. (2018). Education plus exercise versus corticosteroid injection use versus a wait and see approach on global outcome and pain from gluteal tendinopathy: prospective, single blinded, randomised clinical trial. BMJ, 361, k1662. https://doi.org/10.1136/bmj.k1662
Pavlova, A. V., Shim, J. S. C., Moss, R., Maclean, C., Brandie, D., Mitchell, L., Greig, L., Parkinson, E., Alexander, L., Tzortziou Brown, V., Morrissey, D., Cooper, K., & Swinton, P. A. (2023). Effect of resistance exercise dose components for tendinopathy management: a systematic review with meta-analysis. British Journal of Sports Medicine, 57(20), 1327–1334. https://doi.org/10.1136/bjsports-2022-105754
Buttinger, J. N., Johnson, A. J., Twohey, E. E., Gibson, D. J., Nagelli, C. V., Johnson, S. E., & Romero, J. M. (2026). A systematic review of post-procedural rehabilitation protocols following percutaneous needle tenotomy and ultrasonic debridement for gluteal, proximal hamstring, and patellar tendinopathy. American Journal of Physical Medicine & Rehabilitation. online ahead of print (2026-06-17). https://doi.org/10.1097/PHM.0000000000003031
Maag, L., Linder, S., Hackett, L., Mitchkash, M., Farley, T., Lamar, D., Fisher, N., & Burnham, B. (2024). Effectiveness of percutaneous needle tenotomy for tendinopathies: A systematic review. Sports Health, 17(4), 834–842. https://doi.org/10.1177/19417381241275659